AVALO THERAPEUTICS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
AVALO THERAPEUTICS, INC. (AVTX) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $5.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $6.63M, a 232.58% increase year-over-year.
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$1.50M.
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $5.35M, a 435.54% increase year-over-year.
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $1.02M.
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $6.66M.
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$1.11M.
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was -$9.05M.
- AVALO THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was -$3.63M, a 211.75% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.13M 10-Q · filed 2026-08-06 | $10.48M derived: sum of 3 quarters · filed 2026-08-06 | $11.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$1.50M 10-Q · filed 2026-05-13 | $3.85M derived: sum of 2 quarters · filed 2026-05-13 | $4.88M derived: sum of 3 quarters · filed 2026-05-13 | $6.87M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $6.37M derived: sum of 2 quarters · filed 2026-03-23 | $8.36M derived: sum of 3 quarters · filed 2026-08-06 | $6.66M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.01M derived: sum of 2 quarters · filed 2026-08-06 | $1.31M 10-Q · filed 2025-11-06 | $2.31M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $292.00K 10-Q · filed 2026-08-06 | $1.29M derived: sum of 3 quarters · filed 2026-08-06 | $435.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$1.70M 10-Q · filed 2026-05-13 | -$701.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.56M derived: sum of 3 quarters · filed 2026-05-13 | -$1.16M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $999.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $143.00K derived: sum of 2 quarters · filed 2026-03-23 | $541.00K derived: sum of 3 quarters · filed 2026-03-23 | -$1.11M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | -$856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$458.00K derived: sum of 2 quarters · filed 2025-11-06 | -$2.11M 10-Q · filed 2025-11-06 | -$3.07M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.25M 10-Q · filed 2025-08-07 | -$2.21M derived: sum of 3 quarters · filed 2025-08-07 | -$4.67M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$1.65M 10-Q · filed 2025-05-12 | -$2.61M derived: sum of 2 quarters · filed 2025-05-12 | -$5.07M derived: sum of 3 quarters · filed 2025-05-12 | -$5.76M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$3.42M derived: sum of 2 quarters · filed 2025-03-20 | -$4.11M derived: sum of 3 quarters · filed 2025-03-20 | -$9.05M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$3.15M derived: sum of 2 quarters · filed 2024-11-07 | -$8.09M 10-Q · filed 2024-11-07 | -$8.58M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$686.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-12 | -$5.63M 10-Q · filed 2024-08-12 | -$6.12M derived: sum of 3 quarters · filed 2024-08-12 | -$5.72M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$4.94M 10-Q/A · filed 2024-07-11 | -$5.43M derived: sum of 2 quarters · filed 2024-07-11 | -$5.04M derived: sum of 3 quarters · filed 2024-07-11 | -$6.29M derived: sum of 4 quarters · filed 2024-07-11 | ||||
| 2022-12-31 | -$488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$95.00K derived: sum of 2 quarters · filed 2024-03-29 | -$1.34M derived: sum of 3 quarters · filed 2024-03-29 | -$3.63M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$857.00K derived: sum of 2 quarters · filed 2023-11-09 | -$3.14M 10-Q · filed 2023-11-09 | -$2.50M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$3.54M 10-Q · filed 2023-08-03 | -$2.89M derived: sum of 3 quarters · filed 2023-08-03 | -$5.20M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$2.29M 10-Q · filed 2023-05-04 | -$1.64M derived: sum of 2 quarters · filed 2023-05-04 | -$3.95M derived: sum of 3 quarters · filed 2023-05-04 | -$761.00K derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$1.67M derived: sum of 2 quarters · filed 2023-03-29 | $1.53M derived: sum of 3 quarters · filed 2023-03-29 | $3.25M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $880.00K derived: sum of 2 quarters · filed 2022-11-07 | $2.60M 10-Q · filed 2022-11-07 | $632.00K derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | $3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.92M 10-Q · filed 2022-08-04 | $2.94M derived: sum of 3 quarters · filed 2022-08-04 | $5.54M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $1.72M 10-Q · filed 2022-05-05 | -$248.00K derived: sum of 2 quarters · filed 2022-05-05 | $2.34M derived: sum of 3 quarters · filed 2022-05-05 | $1.67M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $619.00K derived: sum of 2 quarters · filed 2022-03-02 | -$54.00K derived: sum of 3 quarters · filed 2022-03-02 | -$196.00K 10-K · filed 2022-03-02 | -$195.71K 10-K · filed 2021-03-08 | |||
| 2020-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.92M derived: sum of 2 quarters · filed 2021-11-09 | $1.78M 10-Q · filed 2021-11-09 | $1.78M 10-Q · filed 2020-11-09 | $1.51M derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | -$815.00K 10-Q · filed 2021-08-02 | -$815.01K 10-Q · filed 2020-08-06 | -$1.08M derived: sum of 3 quarters · filed 2021-08-02 | -$1.34M derived: sum of 4 quarters · filed 2021-08-02 | |||
| 2020-03-31 | -$142.00K 10-Q · filed 2021-05-13 | -$141.87K 10-Q · filed 2020-05-07 | -$403.48K derived: sum of 2 quarters · filed 2021-05-13 | -$663.71K derived: sum of 3 quarters · filed 2021-05-13 | -$9.05M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$261.48K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$521.71K derived: sum of 2 quarters · filed 2021-03-08 | -$8.91M derived: sum of 3 quarters · filed 2021-03-08 | -$6.84M 10-K · filed 2021-03-08 | ||||
| 2019-09-30 | -$260.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$8.65M derived: sum of 2 quarters · filed 2020-11-09 | -$6.57M 10-Q · filed 2020-11-09 | -$4.97M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$8.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$6.31M 10-Q · filed 2020-08-06 | -$4.71M derived: sum of 3 quarters · filed 2020-08-06 | -$919.39K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $2.07M 10-Q · filed 2020-05-07 | $3.68M derived: sum of 2 quarters · filed 2020-05-07 | $7.47M derived: sum of 3 quarters · filed 2020-05-07 | $9.71M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $5.39M derived: sum of 2 quarters · filed 2020-03-11 | $7.63M derived: sum of 3 quarters · filed 2020-03-11 | $7.79M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $6.03M derived: sum of 2 quarters · filed 2019-11-14 | $6.19M 10-Q · filed 2019-11-14 | $7.89M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.40M 10-Q · filed 2019-08-08 | $4.10M derived: sum of 3 quarters · filed 2019-08-08 | $4.66M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $160.63K 10-Q · filed 2019-05-09 | $1.86M derived: sum of 2 quarters · filed 2019-05-09 | $2.43M derived: sum of 3 quarters · filed 2019-05-09 | $2.51M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.27M derived: sum of 2 quarters · filed 2019-03-18 | $2.35M derived: sum of 3 quarters · filed 2019-03-18 | $2.04M 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $563.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $644.56K derived: sum of 2 quarters · filed 2018-11-13 | $341.11K 10-Q · filed 2018-11-13 | -$2.26M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $81.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$222.30K 10-Q · filed 2018-08-09 | -$2.82M derived: sum of 3 quarters · filed 2018-08-09 | -$859.94K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$303.45K 10-Q · filed 2018-05-11 | -$2.90M derived: sum of 2 quarters · filed 2018-05-11 | -$941.09K derived: sum of 3 quarters · filed 2018-05-11 | -$714.47K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$637.63K derived: sum of 2 quarters · filed 2018-04-02 | -$411.02K derived: sum of 3 quarters · filed 2018-04-02 | -$119.50K 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.19M derived: sum of 2 quarters · filed 2017-11-07 | $2.48M 10-Q · filed 2017-11-07 | $3.42M derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2016-06-30 | $226.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $518.14K 10-Q · filed 2017-08-14 | $1.46M derived: sum of 3 quarters · filed 2018-04-02 | $1.27M derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2016-03-31 | $291.52K 10-Q · filed 2017-05-09 | $1.23M derived: sum of 2 quarters · filed 2018-04-02 | $1.05M derived: sum of 3 quarters · filed 2018-04-02 | $1.77M derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2015-12-31 | $942.07K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $756.10K derived: sum of 2 quarters · filed 2018-04-02 | $1.48M derived: sum of 3 quarters · filed 2018-04-02 | $1.12M 10-K · filed 2018-04-02 | ||||
| 2015-09-30 | -$185.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $534.31K derived: sum of 2 quarters · filed 2016-11-08 | $178.98K 10-Q · filed 2016-11-08 | -$940.87K derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | $720.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $364.96K 10-Q · filed 2016-08-15 | -$754.89K derived: sum of 3 quarters · filed 2017-03-14 | |||||
| 2015-03-31 | -$355.32K 10-Q · filed 2016-05-16 | -$1.48M derived: sum of 2 quarters · filed 2017-03-14 | ||||||
| 2014-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$28.40K 10-K · filed 2017-03-14 | ||||||
| 2014-09-30 | $1.09M 10-Q · filed 2015-11-13 | |||||||
| 2013-12-31 | $271.88K 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |